Nephrology News

PHILADELPHIA — An increase in patient education about living organ donation did not result in improvements in changing patient views of pursuing organ transplantation, according to data presented at ASN Kidney Week.

Long-term voclosporin is safe and efficacious for the treatment of lupus nephritis over 3 years, according to data published in Arthritis & Rheumatology.

A woman diagnosed with schizophrenia and psychosis who was nonverbal and nonresponsive for 2 decades recently “woke” after treatment with pulse steroids and cyclophosphamide.

The FDA has cleared an investigational new drug application for AlloNK in combination with rituximab to treat systemic lupus erythematosus in patients with active lupus nephritis, according to a press release from Artiva Biotherapeutics.

ARLINGTON, Texas — An accurate BP measurement is essential to properly diagnose and manage hypertension, yet most providers do not have time to follow the guideline-recommended steps, according to a speaker.

The link between mild-to-moderate acute kidney injury and subsequent worsening kidney function was small and not statistically significant in patients with chronic kidney disease, a recent study found.

A new patient-guided telehealth intervention may relieve fatigue and pain in patients on long-term hemodialysis for end-stage kidney disease, recently published data show.

Taking daily low-dose aspirin was linked to an increased incidence of anemia and a decline in blood iron levels among otherwise healthy older adults, according to the results of research published in Annals of Internal Medicine.

Remission induction strategies based on rituximab and cyclophosphamide each demonstrate similar risks for kidney failure and death in patients with ANCA-associated vasculitis, according to data published in Arthritis & Rheumatology.

The FDA on Tuesday approved letermovir for the prevention of cytomegalovirus disease in high-risk adult kidney transplant recipients, Merck announced.